rs1514246

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000636603.1(CHRNA7):​c.-131-3611A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.592 in 152,080 control chromosomes in the GnomAD database, including 29,576 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.59 ( 29576 hom., cov: 32)

Consequence

CHRNA7
ENST00000636603.1 intron

Scores

3

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.225

Publications

9 publications found
Variant links:
Genes affected
CHRNA7 (HGNC:1960): (cholinergic receptor nicotinic alpha 7 subunit) The nicotinic acetylcholine receptors (nAChRs) are members of a superfamily of ligand-gated ion channels that mediate fast signal transmission at synapses. The nAChRs are thought to be hetero-pentamers composed of homologous subunits. The proposed structure for each subunit is a conserved N-terminal extracellular domain followed by three conserved transmembrane domains, a variable cytoplasmic loop, a fourth conserved transmembrane domain, and a short C-terminal extracellular region. The protein encoded by this gene forms a homo-oligomeric channel, displays marked permeability to calcium ions and is a major component of brain nicotinic receptors that are blocked by, and highly sensitive to, alpha-bungarotoxin. Once this receptor binds acetylcholine, it undergoes an extensive change in conformation that affects all subunits and leads to opening of an ion-conducting channel across the plasma membrane. This gene is located in a region identified as a major susceptibility locus for juvenile myoclonic epilepsy and a chromosomal location involved in the genetic transmission of schizophrenia. An evolutionarily recent partial duplication event in this region results in a hybrid containing sequence from this gene and a novel FAM7A gene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2012]
CHRNA7 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • epilepsy
    Inheritance: Unknown Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000636603.1, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.96).
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.73 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000636603.1. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt

There are no transcript annotations for this variant.

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CHRNA7
ENST00000636603.1
TSL:5
c.-131-3611A>C
intron
N/AENSP00000490513.1A0A1B0GVH2
CHRNA7
ENST00000637183.1
TSL:5
c.-43+49093A>C
intron
N/AENSP00000490365.1A0A1B0GV43
CHRNA7
ENST00000638106.1
TSL:5
c.-378-3611A>C
intron
N/AENSP00000490413.1A0A1B0GV86

Frequencies

GnomAD3 genomes
AF:
0.592
AC:
89985
AN:
151962
Hom.:
29580
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.342
Gnomad AMI
AF:
0.704
Gnomad AMR
AF:
0.543
Gnomad ASJ
AF:
0.661
Gnomad EAS
AF:
0.193
Gnomad SAS
AF:
0.697
Gnomad FIN
AF:
0.838
Gnomad MID
AF:
0.601
Gnomad NFE
AF:
0.735
Gnomad OTH
AF:
0.589
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.592
AC:
89992
AN:
152080
Hom.:
29576
Cov.:
32
AF XY:
0.596
AC XY:
44293
AN XY:
74330
show subpopulations
African (AFR)
AF:
0.342
AC:
14182
AN:
41466
American (AMR)
AF:
0.542
AC:
8278
AN:
15284
Ashkenazi Jewish (ASJ)
AF:
0.661
AC:
2292
AN:
3470
East Asian (EAS)
AF:
0.193
AC:
1001
AN:
5176
South Asian (SAS)
AF:
0.696
AC:
3349
AN:
4814
European-Finnish (FIN)
AF:
0.838
AC:
8865
AN:
10576
Middle Eastern (MID)
AF:
0.588
AC:
173
AN:
294
European-Non Finnish (NFE)
AF:
0.735
AC:
49974
AN:
67976
Other (OTH)
AF:
0.585
AC:
1236
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1580
3160
4740
6320
7900
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
738
1476
2214
2952
3690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.668
Hom.:
4458
Bravo
AF:
0.553
Asia WGS
AF:
0.473
AC:
1648
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.96
CADD
Benign
2.3
DANN
Benign
0.59
PhyloP100
0.23

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs1514246;
hg19: chr15-32319490;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.